-
Lead Pharma Achieves Third Milestone in Sanofi Collaboration for Development of Autoimmune Diseases
b3cnewswire
November 24, 2017
Sanofi's research collaboration achieved a third milestone triggering undisclosed milestone payments
-
New initiative to accelerate development of universal influenza vaccines
europeanpharmaceuticalreview
October 30, 2017
Universal Influenza Vaccine Initiative will address the underlying scientific barrier impeding the development of broadly protective, universal influenza vaccines…
-
Breakthrough study could revolutionise MS treatment
pharmafile
October 16, 2017
The results of a study from the University of California, San Francisco will be welcomed with a certain excitement from all quarters, given that it seems to show the repair of myelin damaged by multiple sclerosis
-
Janssen deal gives new kid in town Provention two immune candidates
fiercebiotech
September 22, 2017
Right on the heels of a $28 million seed financing, Provention Bio has snapped up two inflammatory bowel disease candidates from Janssen that should make it a double clinical-stage biotech next year.
-
WuXi AppTec promotes prospects of immunotherapy
biospectrumasia
August 11, 2017
Over the next 10-years, we will see significantly greater breakthroughs as the industry’s understanding of the immune system improves.
-
Immune system attacks the brain in Alzheimer's, study suggests
pharmafile
June 23, 2017
New research has identified direct evidence that the body’s immune system attacks the brain in Parkinson’s disease.
-
Alpine Immune Sciences boosts prospects with Nivalis merger
pharmafile
April 21, 2017
Alpine Immune Sciences has agreed a deal to merge with Nivalis Therapeutics, in an all-stock deal. The merger...